Safety and Efficacy of Direct Oral Anticoagulants as Thromboprophylaxis in Patients With Multiple Myeloma Receiving a Lenalidomide-Based Induction Regimen

Safety and Efficacy of Direct Oral Anticoagulants as Thromboprophylaxis in Patients With Multiple Myeloma Receiving a Lenalidomide-Based Induction Regimen


Connecting Science to Practice

Multiple myeloma (MM) is a type of blood cancer that carries
a high risk for developing venous thromboembolism
(VTE). Although most data support using aspirin, warfarin,
or an injectable blood…

Continue Reading